Why Xero Limited shares are storming higher today

The Xero Limited (ASX:XRO) share price has stormed to a multi-year high this morning after UBS took its sell rating off its shares…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Xero Limited (ASX: XRO) share price has been amongst the best performers on the local share market on Wednesday morning.

At the time of writing the accounting software platform provider's shares are up a sizeable 4% to a multi-year high of $39.75.

Why are Xero's shares on the rise today?

With no news out of the company, today's push higher appears to be related to a broker note out of UBS.

According to the note, UBS has upgraded Xero's shares to a neutral rating from sell following a change of analyst.

While a neutral rating isn't normally something to get excited about, the removal of the sell rating from one of the most influential brokers in Australia certainly is.

Furthermore, the broker has increased its price target up to $42.50, approximately 11% higher than its last close price.

The new analyst covering Xero believes that the company is transitioning from a loss-making tech company into a self-funding one with a proven business model and sizeable structural growth opportunities.

In addition to this, the broker has pointed to regulatory changes in the United Kingdom in FY 2019 as being a potential industry-changing event and a great opportunity for Xero.

Should you invest?

UBS may only have a neutral rating on its shares right now, but I remain confident that Xero would be a great buy and hold investment option due to the quality of its product and the strong long-term growth potential it has in key markets across the world.

And while its shares may be a little on the expensive side today, I believe that as it scales it will comfortably grow into its premium valuation.

In light of this, I would suggest investors buy its shares ahead of industry peers Myob Group Ltd (ASX: MYO) and Reckon Limited (ASX: RKN).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »